Related references
Note: Only part of the references are listed.Hypoxia signaling: Challenges and opportunities for cancer therapy
Mircea Ivan et al.
SEMINARS IN CANCER BIOLOGY (2022)
Nanobodies-Little helpers unravelling intracellular signaling
Teresa R. Wagner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Immunogenicity Risk Profile of Nanobodies
Chloe Ackaert et al.
FRONTIERS IN IMMUNOLOGY (2021)
Unbiased Immunization Strategy Yielding Specific Nanobodies against Macadamia Allergen of Vicilin-like Protein for Immunoassay Development
Yaozhong Hu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
HIF-1a expression and differential effects on survival in patients with oral cavity, larynx, and oropharynx squamous cell carcinomas
Justin E. Swartz et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)
Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia
Zan Li et al.
REDOX BIOLOGY (2019)
Intrabody against prolyl hydroxylase 2 promotes angiogenesis by stabilizing hypoxia-inducible factor-1α
Liangzhong Zhao et al.
SCIENTIFIC REPORTS (2019)
FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma
Chitrangda Srivastava et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Necrostatin-1 protects C2C12 myotubes from CoCl2-induced hypoxia
Rui Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Combinatorial Design of a Nanobody that Specifically Targets Structured RNAs
F. Cawez et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Role of HIF-1 in Cancer Progression: Novel Insights. A Review
Aldo Pezzuto et al.
CURRENT MOLECULAR MEDICINE (2018)
Changes in Cancer Treatment Mabs, Mibs, Mids, Nabs, and Nibs
Joseph D. Tariman
NURSING CLINICS OF NORTH AMERICA (2017)
Generation of Nanobodies against SlyD and development of tools to eliminate this bacterial contaminant from recombinant proteins
Yaozhong Hu et al.
PROTEIN EXPRESSION AND PURIFICATION (2017)
State of the art in anti-cancer mAbs
S. M. Chiavenna et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Hypoxic control of metastasis
Erinn B. Rankin et al.
SCIENCE (2016)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
A general protocol for the generation of Nanobodies for structural biology
Els Pardon et al.
NATURE PROTOCOLS (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
Gregg L. Semenza
Annual Review of Pathology-Mechanisms of Disease (2013)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
Cecile Vincke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Structural Basis for Binding of Hypoxia-Inducible Factor to the Oxygen-Sensing Prolyl Hydroxylases
Rasheduzzaman Chowdhury et al.
STRUCTURE (2009)
The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer
Howard R. Mellor et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Review: Implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions
An Wouters et al.
ONCOLOGIST (2007)
Targeting and tracing antigens in live cells with fluorescent nanobodies
Ulrich Rothbauer et al.
NATURE METHODS (2006)
Targeted therapy of cancer: New prospects for antibodies and immunoconjugates
Robert M. Sharkey et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2006)
Hypoxia signalling in cancer and approaches to enforce tumour regression
Jacques Pouyssegur et al.
NATURE (2006)
Functions of the Per/ARNT/Sim domains of the hypoxia-inducible factor
JS Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies
D Saerens et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1)
AE Greijer et al.
JOURNAL OF PATHOLOGY (2005)
Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1
KJ Williams et al.
RADIOTHERAPY AND ONCOLOGY (2005)
HIF-1α induces genetic instability by transcriptionally downregulating MutSα expression
M Koshiji et al.
MOLECULAR CELL (2005)
Structural basis for PAS domain heterodimerization in the basic helix-loop-helix-PAS transcription factor hypoxia-inducible factor
PJA Erbel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α
Y Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron
SJ Mandriota et al.
CANCER CELL (2002)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
